These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14551273)

  • 1. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.
    Lu DS; Raman SS; Limanond P; Aziz D; Economou J; Busuttil R; Sayre J
    J Vasc Interv Radiol; 2003 Oct; 14(10):1267-74. PubMed ID: 14551273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.
    Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
    Radiology; 2014 Mar; 270(3):888-99. PubMed ID: 24475820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
    Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
    Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
    Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
    Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation.
    Schindera ST; Nelson RC; DeLong DM; Clary B
    J Vasc Interv Radiol; 2006 Oct; 17(10):1631-7. PubMed ID: 17057005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
    Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
    J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
    Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
    J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
    Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
    Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
    Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.
    Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N
    Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
    Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
    J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
    Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.